Search everything Menu Investor relations Our science-led strategy is key to delivering long-term value for patients, employees and shareholders. NYSE: MRK November 25, 2021 6:07 pm ET Delayed at least 20 minutes View stock information Latest news, events & financials NewsEvents & presentationsFinancials November 24, 2021 Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference November 22, 2021 Merck Completes Acquisition of Acceleron Pharma Inc. November 19, 2021 Merck Completes Tender Offer to Acquire Acceleron Pharma Inc. View all Merck & Co., Inc. at the 4th Annual Evercore ISI HealthCONx Conference Icons / 16 / Cal Created with Sketch. Add to Calendar Icons / 16 / Microphone Created with Sketch. Webcast See full agenda Our pipeline shows our relentless pursuit of the next breakthrough. Explore our pipeline Phase II programs 71 Phase III programs 25 Under review 3 Our leadership Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy. Leadership Corporate responsibility Supporting the future of our business and the health and well-being of patients, people and communities around the world. Download our 2020/2021 ESG Progress Report We're led by our science We follow the science to our next breakthrough, leaving no stone unturned. View our stories Innovation Our third-quarter 2021 financial results Merck announced third-quarter 2021 worldwide sales of $13.2 billion, 20% above third-quarter 2020. Excluding the impact from foreign exchange, sales grew 19%. The company anticipates full-year 2021 revenue range to be between $47.4 billion and $47.9 billion, including a positive impact from foreign exchange of approximately 1.5%. Take a look at the infographic below for […] Read more Next: Our third-quarter 2021 financial results Next: Our new London Discovery Research Center site Previous Next Sign up for email alerts Receive company news, updates and other information Unsubscribe from email alerts For questions, please contact our team. Contact investor relations (908) 740 – 1468 investor_relations@merck.com Related links About our company Discover how we invent for life Financial information Find information about our quarterly reports, annual reports & proxy and SEC filings Stock information See stock quotes and charts on a monthly, quarterly or yearly basis Connect with us on social For patients and health care professionals MerckHelps Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients Merck Access Program Information about insurance coverage and financial assistance options for eligible patients Clinical trials Learn about our clinical trials and find available studies Merck Manuals Medical information source covering thousands of topics in all fields of medicine Corporate responsibility Environmental, Social, Governance (ESG) Report Reporting on our commitment to operating responsibly to benefit society Merck for Mothers An initiative to create a world where no woman has to die giving life About Merck Merck Animal Health The global animal health business unit of Merck Forward-looking statement Cookie policy Cookie Preferences Privacy Transparency disclosure Terms of use Sitemap Copyright © 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. This Site Uses Cookies and Your Privacy Choice Is Important to Us We suggest you choose Customize My Settings to make your individualized choices. Accept All Cookies means that you are choosing to accept third-party Cookies and that you understand this choice. See our Privacy Policy Customize My Settings Accept All Cookies